Bibliografisk note

Funding Information:
receiving grants from Sanofi, Regeneron, and Infraredx to Inselspital and speaker fees from Sanofi during the conduct of the study and grants from Abbott, Heartflow, Boston Scientific, and Biotronik to Inselspital and grants from Abbott, Amgen, AstraZeneca, Occlutech, Sanofi, Canon, and Medtronic for speaker and consultation fees outside the submitted work. Dr Losdat reported affiliation with CTU Bern, University of Bern, which has a staff policy of not accepting honoraria or consultancy fees; however, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by not-for-profit and for-profit organizations, in particular, pharmaceutical and medical device companies provide direct funding to some of these studies (for an up-to-date list of CTU Bern's conflicts of interest see http://www.ctu. unibe.ch/research/declaration_of_interest/index_ eng.html). Dr Iglesias reported receiving grants to his institution from Biotronik, AstraZeneca, Abbott Vascular, Philips Volcano, Terumo Corp, Biosensors, and Medtronic and personal fees from Biotronik, AstraZeneca, Philips Volcano, Terumo Corp, Bristol Myers Squibb/Pfizer, Cardinal Health, Medtronic, and Novartis outside the submitted work. Dr van Geuns reported receiving grants from Amgen, InfraRedx, AstraZeneca, and Sanofi and personal fees from Abbott outside the submitted work. Dr Radu Juul Jensen reported having taken up a full-time position at the pharmaceutical company Novo Nordisk after completion of the trial and initial analysis; the new work is unrelated to the work in the current article. Dr Stortecky reported receiving grants to the institution from Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott and personal fees from Boston Scientific, Teleflex, and BTG outside the submitted work. Dr Spirk reported receiving personal fees from Sanofi-Aventis (Suisse) outside the submitted work. Dr Siontis reported receiving personal fees from Abbott Vascular outside the submitted work. Dr Matter reported receiving personal fees from Amgen as a consultant and speaker during the conduct of the study and grants to the institution from EliLilly, AstraZeneca, Novartis, MSD, Swiss National Science Foundation, and Swiss Heart Foundation; personal fees from Novartis to the institution; and nonfinancial support from Roche Diagnostics outside the submitted work. Dr Daemen reported receiving institutional grant/ research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor Medical. Dr Heg reported the following: https:// www.ctu.unibe.ch/research/declaration_of_ interest/index_eng.html. Dr Windecker reported receiving research and educational grants to the institution from Abbott, Abiomed, Amgen, AstraZeneca, Bayer, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardinal Health, CardioValve, Corflow Therapeutics, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Guerbet, InfraRedx, Janssen-Cilag, Johnson & Johnson, Medicure, Medtronic, Merck Sharp & Dohme, Miracor Medical, Novartis, NovoNordisk, Organon, OrPha Suisse, Pfizer, Polares, Regeneron, Sanofi-Aventis, Servier, Sinomed, Terumo, Vifor, and V-Wave outside the submitted work and serving as an unpaid advisory board member and/or unpaid member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, Astra Zeneca, Bayer, Boston Scientific, Biotronik, Bristol Myers Squibb, Edwards Lifesciences, Janssen, MedAlliance, Medtronic, Novartis, Polares, Recardio, Sinomed, Terumo, V-Wave and Xeltis, but has not received personal payments by pharmaceutical companies or device manufacturers, and is a member of the steering/ executive committee group of several investigator-initiated trials that receive funding by industry without impact on his personal remuneration. Dr Engstrøm reported receiving personal fees from Abbott for speaker fees and serving on an advisory board outside the submitted work. Dr Lang reported receiving grants and personal fees from Janssen, and AOPOrphan, personal fees from MSD, and grants from Neutrolis outside the submitted work. Dr Koskinas reported receiving grants from Sanofi, Regeneron, and Infraredx during the conduct of the study and personal fees from Amgen and Daiichi Sankyo outside the submitted work. No other disclosures were reported.

Publisher Copyright:
© 2022 American Medical Association. All rights reserved.